23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...

加利福尼亚州桑尼维尔 - 23andMe Holding Co. (NASDAQ:ME) 公布的2024财年第二季度亏损超出预期，尽管收入超过预估，导致盘后交易中股价下跌1.74%。 这家基因和预防性健康公司在截至9月30日的季度内每股亏损2.32美元，远高于分析师预期的每股亏损0.16美元。然而，收入达到4407万美元，超过了3641万美元的一致预期。

美国基因技术公司23andMe当地时间11月11日宣布进行业务重组，以精简业务和降低成本。此外，23andMe将停止所有治疗项目的进一步开发。23andMe称，公司将减少200多名员工，约占员工总数的40%。业务重组预计将大幅减少运营开支，每年可节省超过3500万美元的成本。公司预计将产生多至1200万美元的成本和费用，主要与一次性遣散 ...

英为财情Investing.com - 23Andme Holding Co (NASDAQ: ME )星期二发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益低于分析师的预期。

DNA testing company 23andMe is laying off 200+ employees, or about 40% of its workforce. The job cuts are part of a business ...

NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...

The genetic testing company 23andMe is cutting 40% of its workforce and ending its therapeutics program as its stock price ...

The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...

23andMe on Tuesday reported that second-quarter revenue fell to $44.1 million from $50 million a year earlier. The embattled ...

As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.